Dendrion Ventures
InvestorActiveDendrion Ventures is a venture capital firm that provides evergreen capital for MedTech opportunities. The firm describes its mandate as focused on innovative and impactful medical technology investments. It has participated in at least one Series A round — ReEmerge's $37M raise in 2026 — alongside co-investors including U.S. Venture Partners, Santé, Oxford Science Enterprises, 415 Capital, IAG Capital Partners, and The Vertical Group. Beyond its tagline and contact form, the firm's public-facing website discloses no information about fund size, check size, investment stage, team, or geographic focus.
Founder Intel
Sign in to read intel from founders who have worked with Dendrion Ventures.
What founders say about Dendrion Ventures
Be the first to share intel on Dendrion Ventures — it's free.
Get Started FreeRelated on The List
- 2048 Ventures — Investor · New York, NY, United States
- 415 Capital — Investor · Munich, Germany
- 4BIO Capital — Investor · London, United Kingdom
- 8VC — Investor · Austin, TX, USA
- AbbVie Ventures — Investor · Cambridge, MA, United States
Comparing options? Founders discuss fundraising in the forum, or browse the rest of The List.